share_log

中國再生醫學:(1) 建議遷冊;(2) 建議採納存續大綱及新細則;(3) 建議減少股份溢價賬;(4) 建議股本重組;(5) 建議變更每手買賣單位;及(6) 股東特別大會通告

CRMI: (1) PROPOSED CHANGE OF DOMICILE; (2) PROPOSED ADOPTION OF MEMORANDUM OF CONTINUANCE AND NEW BYE-LAWS; (3) PROPOSED REDUCTION OF SHARE PREMIUM ACCOUNT; (4) PROPOSED CAPITAL REORGANISATION; (5) PROPOSED CHANGE IN BOARD LOT SIZE; AND (6) NOTICE OF EXTR

Sep 17, 2020 06:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more